| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 50.28B | 48.30B | 44.11B | 35.66B | 29.20B |
| Gross Profit | 8.74B | 7.58B | 7.00B | 4.38B | 4.79B |
| EBITDA | 11.45B | 10.56B | 9.75B | 7.92B | 5.91B |
| Net Income | 3.84B | 3.14B | 3.01B | 2.36B | 313.18M |
Balance Sheet | |||||
| Total Assets | 84.46B | 82.95B | 83.25B | 77.18B | 73.31B |
| Cash, Cash Equivalents and Short-Term Investments | 13.08B | 11.47B | 12.72B | 9.23B | 10.82B |
| Total Debt | 13.16B | 10.56B | 21.62B | 22.22B | 23.44B |
| Total Liabilities | 37.31B | 38.52B | 40.99B | 37.29B | 35.10B |
| Stockholders Equity | 46.57B | 43.80B | 41.64B | 39.33B | 38.03B |
Cash Flow | |||||
| Free Cash Flow | 5.40B | 4.99B | 3.62B | 2.76B | 3.67B |
| Operating Cash Flow | 11.29B | 11.02B | 13.10B | 6.90B | 7.42B |
| Investing Cash Flow | -5.17B | -5.08B | -7.46B | -3.73B | -4.73B |
| Financing Cash Flow | -4.04B | -6.46B | -3.28B | -4.87B | -4.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$3.27B | 5.50 | 8.78% | 3.59% | 10.16% | 49.48% | |
66 Neutral | HK$1.10B | 21.20 | 2.87% | 2.83% | -59.96% | -83.53% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | HK$70.14B | 7.80 | 8.45% | 3.59% | 2.58% | 7.10% | |
58 Neutral | HK$509.37M | 3.80 | 12.68% | ― | -36.59% | 48.63% | |
50 Neutral | HK$8.21B | -107.60 | -20.81% | ― | 17.21% | 59.09% | |
48 Neutral | HK$424.11M | -0.13 | -11.00% | ― | -2.11% | -779.00% |